5-Bromopentanoic acid (CAS 2067-33-6) is a vital building block in the US API intermediates market, particularly for the synthesis of advanced PI3K and topoisomerase IB inhibitors where a Pharma/API purity of 99% is mandatory to ensure clinical efficacy and regulatory alignment. 5-Bromovaleric acid is increasingly requ...